These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9786731)

  • 1. Interferon in wonderland.
    Koretz RL
    Gastroenterology; 1998 Oct; 115(4):1027-9. PubMed ID: 9786731
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C.
    Wong JB; Davis GL; Pauker SG
    Am J Med; 2000 Apr; 108(5):366-73. PubMed ID: 10759092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C.
    Bennett WG; Inoue Y; Beck JR; Wong JB; Pauker SG; Davis GL
    Ann Intern Med; 1997 Nov; 127(10):855-65. PubMed ID: 9382363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C therapy: is it really worth it?
    Johanson JF
    Am J Gastroenterol; 1999 May; 94(5):1412-3. PubMed ID: 10235231
    [No Abstract]   [Full Text] [Related]  

  • 5. Interferon alfa for chronic hepatitis C infection.
    Delgado Fernández M; Zambrana García JL; Díez García F
    Lancet; 1999 Feb; 353(9151):499-500. PubMed ID: 9989747
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic hepatitis C: early intervention.
    Koff RS
    Hosp Pract (1995); 1998 Jun; 33(6):101-5, 108, 111-4. PubMed ID: 9636354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of treatments for chronic hepatitis C.
    Wong JB
    Am J Med; 1999 Dec; 107(6B):74S-78S. PubMed ID: 10653463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Babu S
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929872
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Desai HG
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929870
    [No Abstract]   [Full Text] [Related]  

  • 10. Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs.
    Wong JB; Bennett WG; Koff RS; Pauker SG
    JAMA; 1998 Dec 23-30; 280(24):2088-93. PubMed ID: 9875876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.
    Salomon JA; Weinstein MC; Hammitt JK; Goldie SJ
    JAMA; 2003 Jul; 290(2):228-37. PubMed ID: 12851278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Nagral A
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929871
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic hepatitis C.
    Kim WR; Poterucha JJ; Gross JB
    Hepatology; 2000 Mar; 31(3):807-8. PubMed ID: 10722315
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Wong JB; Poynard T; Ling MH; Albrecht JK; Pauker SG
    Am J Gastroenterol; 2000 Jun; 95(6):1524-30. PubMed ID: 10894590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decisions, decisions, decisions.
    Koretz RL
    Gastroenterology; 2000 Jun; 118(6):1268-70. PubMed ID: 10833503
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6.
    Kapol N; Lochid-Amnuay S; Teerawattananon Y
    BMC Gastroenterol; 2016 Aug; 16(1):91. PubMed ID: 27492396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon treatment for chronic hepatitis B or C infection: costs and effectiveness.
    Wong JB
    Acta Gastroenterol Belg; 1998; 61(2):238-42. PubMed ID: 9658620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha for chronic hepatitis C: reducing the uncertainties.
    Koff RS
    Ann Intern Med; 1997 Nov; 127(10):918-20. PubMed ID: 9382371
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of alpha 2b versus lymphoblastoid interferon in treatment of chronic hepatitis C. A randomized trial.
    González Sánchez M; Palacios A; Caballero T; Torres Fernández-Piñar C; Bellot V; Ruiz Extremera A; Salmerón J
    Rev Esp Enferm Dig; 1998 Aug; 90(8):553-62. PubMed ID: 9780788
    [No Abstract]   [Full Text] [Related]  

  • 20. Exacerbation of psoriasis by interferon-alpha therapy for hepatitis C.
    Downs AM; Dunnill MG
    Clin Exp Dermatol; 2000 Jun; 25(4):351-2. PubMed ID: 10971502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.